World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
68
Citations
16329
World Ranking
2756
National Ranking
1287

Overview

Prisca Honore is affiliated with the University of Minnesota in the United States. Their research primarily spans the fields of Medicine and Immunology and Microbiology, focusing on subfields such as Dermatology, Immunology, Surgery, Rheumatology, and Molecular Biology.

The main topics addressed in their work include Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Hidradenitis Suppurativa and Treatments, Colorectal and Anal Carcinomas, Urticaria and Related Conditions, Retinoids in leukemia and cellular processes, and Anorectal Disease Treatments and Outcomes.

Their recent publications include the following papers:

  • Phospholipase A2 enzymes represent a shared pathogenic pathway in psoriasis and pityriasis rubra pilaris, 2021, JCI Insight
  • Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention, 2020, Experimental Dermatology
  • Cytokine induced 3-D organotypic psoriasis skin model demonstrates distinct roles for NF-κB and JAK pathways in disease pathophysiology, 2022, Experimental Dermatology
  • Importance of PLD2 in an IL-23 driven psoriasiform dermatitis model and potential link to human psoriasis, 2023, The Journal of Dermatology
  • Small molecule interleukin (IL) 17A/A antagonists and antibodies blocking both IL17A/A and IL17A/F demonstrate equivalent degrees of efficacy in preclinical models of skin and joint inflammation, 2025, Journal of Pharmacology and Experimental Therapeutics

Key frequent coauthors collaborating with Prisca Honore comprise:

  • J. Wetter
  • Viktor Todorović
  • Victoria Scott
  • Kathleen M. Smith
  • Paul W. Harms

Their publications appear predominantly in the following venues:

  • Experimental Dermatology
  • JCI Insight
  • The Journal of Dermatology
  • Journal of Pharmacology and Experimental Therapeutics
  • The FASEB Journal

Best Publications

  • Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor.

    Patrick W. Mantyh;Scott D. Rogers;Scott D. Rogers;Prisca Honore;Prisca Honore;Brian J. Allen;Brian J. Allen

  • Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain

    Matthew J. Schwei;Prisca Honore;Scott D. Rogers;Janeen L. Salak-Johnson

  • Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons.

    P Honore;S.D Rogers;M.J Schwei;J.L Salak-Johnson

  • A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat

    Michael F. Jarvis;Prisca Honore;Char Chang Shieh;Mark Chapman

  • Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

    Prisca Honore;Nancy M. Luger;Nancy M. Luger;Mary Ann C. Sabino;Mary Ann C. Sabino;Matthew J. Schwei;Matthew J. Schwei

  • A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat

    Prisca Honore;Diana Donnelly-Roberts;Marian T. Namovic;Gin Hsieh

  • A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat

    Michael F. Jarvis;Edward C. Burgard;Steve McGaraughty;Prisca Honore

  • Transmission of chronic nociception by spinal neurons expressing the substance P receptor.

    Michael L. Nichols;Michael L. Nichols;Brian J. Allen;Brian J. Allen;Scott D. Rogers;Scott D. Rogers;Joseph R. Ghilardi;Joseph R. Ghilardi

  • TRPV1 Receptors in the CNS Play a Key Role in Broad-Spectrum Analgesia of TRPV1 Antagonists

    M. Cui;P. Honore;C. Zhong;D. Gauvin

  • A-425619 [1-Isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a Novel Transient Receptor Potential Type V1 Receptor Antagonist, Relieves Pathophysiological Pain Associated with Inflammation and Tissue Injury in Rats

    Prisca Honore;Carol T Wismer;Joseph P Mikusa;Chang Z Zhu

  • Analgesic profile of intrathecal P2X3 antisense oligonucleotide treatment in chronic inflammatory and neuropathic pain states in rats

    Prisca Honore;Karen Kage;Joseph Mikusa;Andrew T. Watt

  • Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X7 Antagonists

    Derek W. Nelson;Robert J. Gregg;Michael E. Kort;Arturo Perez-Medrano

  • Osteoprotegerin Diminishes Advanced Bone Cancer Pain

    Nancy M. Luger;Prisca Honore;Mary Ann C. Sabino;Matthew J. Schwei

  • Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain.

    Nancy M. Luger;Mary Ann C. Sabino;Matthew J. Schwei;David B. Mach

  • P2X7-related modulation of pathological nociception in rats

    S. McGaraughty;K.L. Chu;M.T. Namovic;D.L. Donnelly-Roberts

  • Effects of A‐317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration

    Steve McGaraughty;Carol T Wismer;Chang Z Zhu;Joseph Mikusa

  • Involvement of the TTX-resistant sodium channel Nav 1.8 in inflammatory and neuropathic, but not post-operative, pain states.

    S K Joshi;Joseph P Mikusa;Gricelda Hernandez;Scott Baker

  • Spinal Substance P Receptor Expression and Internalization in Acute, Short-Term, and Long-Term Inflammatory Pain States

    Prisca Honoré;Prisca Honoré;Patrick M. Menning;Patrick M. Menning;Scott D. Rogers;Scott D. Rogers;Michael L. Nichols;Michael L. Nichols

  • Electrophysiological and in vivo characterization of A-317567, a novel blocker of acid sensing ion channels.

    G.R. Dubé;Sonya G. Lehto;Nicole M. Breese;Scott J. Baker

  • Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.

    Arthur Gomtsyan;Erol K Bayburt;Robert G Schmidt;Guo Zhu Zheng

Frequent Co-Authors

Jean-Marie Besson
Jean-Marie Besson Grenoble Alpes University
Patrick W. Mantyh
Patrick W. Mantyh University of Arizona
Scott D. Rogers
Scott D. Rogers University of Minnesota
Victoria Chapman
Victoria Chapman University of Nottingham
Steve McGaraughty
Steve McGaraughty AbbVie (United States)
Gerard B. Fox
Gerard B. Fox Georgetown University Medical Center
Joseph R. Ghilardi
Joseph R. Ghilardi ThreeWire, Inc.
Donald A. Simone
Donald A. Simone University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Prisca Honore

Trending Scientists

Recently Published Articles